Clinical trial
A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level
NCT07287449 is registered in ClinicalTrials.gov with Dymicron as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level
- Lead sponsor
- Dymicron
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 5, 2026
- Completion date
- July 31, 2029
- Enrollment
- 164 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical disc disease